首页> 美国卫生研究院文献>Journal of Bacteriology >Biochemical characterization of avirulent Agrobacterium tumefaciens chvA mutants: synthesis and excretion of beta-(1-2)glucan.
【2h】

Biochemical characterization of avirulent Agrobacterium tumefaciens chvA mutants: synthesis and excretion of beta-(1-2)glucan.

机译:无毒根癌农杆菌chvA突变体的生化特征:β-(1-2)葡聚糖的合成和排泄。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The chvA gene product of Agrobacterium tumefaciens is required for virulence and attachment of bacteria to plant cells. Three chvA mutants were studied. In vivo, they were defective in the synthesis, accumulation, and secretion of beta-(1-2)glucan; however, the 235-kilodalton (kDa) protein known to be involved in the synthesis of beta-(1-2)glucan (A. Zorreguieta and R. Ugalde, J. Bacteriol. 167:947-951, 1986) was present and active in vitro. was present and active in vitro. Two molecular forms of cyclic beta-(1-2)glucan, designated types I and II, were resolved by gel chromatography. Type I beta-(1-2)glucan was substituted with nonglycosidic residues, and type II beta-(1-2)glucan was nonsubstituted. Wild-type cells accumulated type I beta-(1-2)glucan, and chvA mutant cells accumulated mainly type II beta-(1-2)glucan and a small amount of type I beta-(1-2)glucan. Inner membranes of wild-type and chvA mutants formed in vitro type II nonsubstituted beta-(1-2)glucan. A 75-kDa inner membrane protein is proposed to be the chvA gene product. chvA mutant inner membranes had increased levels of 235-kDa protein; partial trypsin digestion patterns suggested that the 235-kDa protein (the gene product of the chvB region) and the gene product of the chvA region form a complex in the inner membrane that is involved in the synthesis, secretion, and modification of beta-(1-2)glucan. All of the defects assigned to the chvA mutation were restored after complementation with plasmid pCD522 containing the entire chvA region.
机译:根癌土壤杆菌的chvA基因产物是细菌的毒性和将其附着于植物细胞所必需的。研究了三个chvA突变体。在体内,它们在β-(1-2)葡聚糖的合成,积累和分泌方面存在缺陷。但是,目前存在已知与β-(1-2)葡聚糖合成有关的235千达尔顿(kDa)蛋白(A. Zorreguieta和R. Ugalde,J. Bacteriol。167:947-951,1986),并且在体外活跃。存在并且在体外活跃。通过凝胶色谱法拆分了两种分子形式的环状β-(1-2)葡聚糖,分别命名为I和II型。 I型β-(1-2)葡聚糖被非糖苷残基取代,II型β-(1-2)葡聚糖未被取代。野生型细胞积累I型β-(1-2)葡聚糖,而chvA突变细胞则主要积累II型β-(1-2)葡聚糖和少量I型β-(1-2)葡聚糖。野生型和chvA突变体的内膜形成了体外II型非取代的β-(1-2)葡聚糖。有人提出一种75 kDa的内膜蛋白是chvA基因产物。 chvA突变体内膜的235-kDa蛋白水平升高;胰蛋白酶的部分消化模式表明235-kDa蛋白(chvB区的基因产物)和chvA区的基因产物在内膜中形成复合物,该复合物涉及β-(( 1-2)葡聚糖。与包含整个chvA区的质粒pCD522互补后,恢复了分配给chvA突变的所有缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号